How should multiple intracranial aneurysms and a splenic artery aneurysm be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Multiple Intracranial and Splenic Artery Aneurysms

For multiple intracranial aneurysms, refer to a high-volume center for individualized treatment planning considering endovascular coiling as first-line for most locations (especially basilar apex) except middle cerebral artery aneurysms where microsurgical clipping is preferred; for the splenic artery aneurysm, pursue endovascular embolization if >2 cm or symptomatic, otherwise observe with serial imaging. 1

Intracranial Aneurysm Management

Critical Decision Factors

The presence of multiple aneurysms is itself a high-risk feature that warrants treatment consideration 1. Your management algorithm should prioritize:

  • Size, location, and morphology of each aneurysm
  • Patient age (>65 years favors observation for small lesions)
  • Documented growth on serial imaging
  • Family history of cerebral aneurysm or prior subarachnoid hemorrhage

Treatment Selection Algorithm

Endovascular coiling is preferred over microsurgical clipping for most unruptured intracranial aneurysms due to lower procedural morbidity, mortality, shorter hospital stays, and reduced costs, though it carries higher recurrence rates 1. The guidelines specifically note:

  • Basilar apex and vertebrobasilar confluence aneurysms: Endovascular repair is advantageous
  • Middle cerebral artery aneurysms: Microsurgery shows better outcomes
  • Patients >60 years: Endovascular approach strongly favored since recurrence risk becomes less relevant over their lifetime 1

Critical Caveats

Treatment must occur at a high-volume center (>20 cases annually) as outcomes are significantly inferior at low-volume centers 1. This is a Class I recommendation with Level B evidence.

For small asymptomatic aneurysms in patients >65 years with medical comorbidities, observation with serial imaging is reasonable when hemorrhage risk is low based on size, location, and morphology 1.

Splenic Artery Aneurysm Management

Treatment Threshold Algorithm

Endovascular treatment is now first-line therapy for splenic artery aneurysms and should be pursued when 2, 3, 4:

  • Size >2 cm (most consistent threshold across studies)
  • Symptomatic (abdominal pain)
  • Documented growth on serial imaging
  • Women of childbearing age (though recent data shows this is often not followed in practice 5)
  • Pregnancy or liver transplant recipients (high rupture risk)
  • Any pseudoaneurysm (all require treatment)

Observation Criteria

For aneurysms <2 cm that are asymptomatic and calcified, observation is reasonable 6, 5. Recent natural history data shows:

  • Mean growth rate of only 0.166-0.172 mm/year for aneurysms <20 mm 5
  • Rupture risk is negligible for small aneurysms (only 1 rupture in 853 patients over 4 years, occurring in a 25 mm aneurysm) 5
  • Calcification correlates with decreased size and likely stability 6

Endovascular Technique

The most effective approach uses coil embolization with or without covered stent placement, achieving technical success rates of 95.5% 7. For complicated anatomies (origin aneurysms, aberrant vessels), dense embolization of the sac and outflow artery with collateral embolization provides durable exclusion 7.

Mortality with endovascular treatment is 0.5% versus 4.9% with open surgery, though this difference was not statistically significant in pooled analysis 3. Endovascular repair demonstrates mean 1.5 mm regression in aneurysm size over 2 years with durable results 6.

Integrated Management Strategy

Prioritization

Address the intracranial aneurysms first as they carry higher morbidity and mortality risk from rupture compared to splenic artery aneurysms. The splenic aneurysm can be addressed in a staged fashion unless it meets high-risk criteria (>2 cm, symptomatic, or in a woman of childbearing age).

Follow-up Protocol

  • Intracranial aneurysms: Early post-treatment imaging to document obliteration degree, then increased frequency for incompletely treated aneurysms to detect recurrence and de novo formation 1
  • Splenic artery aneurysm: If observed, serial CT imaging at 6-12 month intervals given slow growth rates of 0.2 mm/year 6, 5

Common Pitfall

Do not attempt treatment at a low-volume center for the intracranial aneurysms—this is associated with significantly worse outcomes and warrants referral 1.

References

Research

Endovascular and surgical management of splenic artery aneurysms.

Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES, 2024

Research

Aneurysms of the splenic artery - a review.

The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland, 2010

Research

The contemporary management of splenic artery aneurysms.

Journal of vascular surgery, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.